Enhancing Prospective Thinking in Early Recovery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stimulant Use
- Sponsor
- Indiana University
- Enrollment
- 88
- Locations
- 1
- Primary Endpoint
- Reduced Use of Drug Using Days
- Status
- Recruiting
- Last Updated
- 7 months ago
Overview
Brief Summary
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing stimulant use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering stimulant use disorder (StUD) persons. The main question[s] this trial aims to answer are:
- Will the Virtual Reality (VR) intervention decrease the number of stimulant use days?
- Will the VR intervention produce longer abstinence periods during follow-up visits?
- Will the VR intervention increase stimulant drug abstinence rates?
- Will the VR intervention increase future self-identification?
- Will the VR intervention increase self-reported future time perspective?
- Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day?
- Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups?
Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
Investigators
Brandon G. Oberlin, PhD
Assistant Professor
Indiana University
Eligibility Criteria
Inclusion Criteria
- •Abstinence between ≥14 days and ≤1 year
- •At least 18 years old
- •Verbal endorsement of commitment to recovery
- •Outpatient
- •Psychotropic drugs for SUD-comorbidity
- •Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit
- •English comprehension
Exclusion Criteria
- •Unstable medical disorders
- •Less than 18 years old
- •Habitual drug use
- •Smell/taste disorders
- •Unstable psychiatric conditions
- •Extravagant/elaborate face tattoos
Outcomes
Primary Outcomes
Reduced Use of Drug Using Days
Time Frame: Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will reduce drug using days.
Increased Length of Abstinence
Time Frame: Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase the length of abstinence periods.
Increased (overall) Abstinence
Time Frame: Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase abstinence.
Future Self-identification
Time Frame: Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase future self-identification.
Delayed Reward Preference
Time Frame: Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase preference for delayed rewards.
Future Time Perspective
Time Frame: Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase future time perspective.